JCR Pharmaceuticals Co., Ltd. (TYO:4552)

Japan · Delayed Price · Currency is JPY

620.00

+24.00 (4.03%)

Mar 5, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals Business	33.07B	42.87B	34.34B	51.08B	30.09B
Pharmaceuticals Business Growth	-22.86%	24.83%	-32.77%	69.79%	21.40%
Total	33.07B	42.87B	34.34B	51.08B	30.09B
Total Growth	-22.86%	24.83%	-32.77%	69.79%	21.40%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Japan	33.07B	42.87B	34.34B	40.79B	30.09B
Japan Growth	-22.86%	24.83%	-15.80%	35.58%	21.40%
Overseas	-	-	-	10.29B	-
Total	33.07B	42.87B	34.34B	51.08B	30.09B
Total Growth	-22.86%	24.83%	-32.77%	69.79%	21.40%

Source: S&P Global Market Intelligence.